alexa In The Pursuit Of Ideal Hits For Antifungal Research | 66656
ISSN: 2161-0444

Medicinal Chemistry
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

6th World Congress on Medicinal Chemistry and Drug Design

Jeanmart Stephane
Syngenta Crop Protection AG, Switzerland
Posters & Accepted Abstracts: Med Chem (Los Angeles)
DOI: 10.4172/2161-0444-C1-031
Abstract
Worldwide, fungal infections take more than 1.3 million lives each year. In addition, over 300 million people are affected by a serious fungal infection. Three classes of antifungals are mainly used to manage these types of invasive fungal infection. The over-reliance on the same medicines acting on a limited number of modes of action has induced a selection pressure amongst the originally susceptible pathogens. As a consequence, drug resistance has become increasingly common and has diminished the arsenal of effective antifungal drugs. Furthermore, some drugs have additional significant limitations. For example, echinocandins need to be administrated intravenously due to their poor oral bioavailability, and amphotericin B has been known to induce adverse nephrotoxicity. This clearly shows the strong need for new molecules which are able to control pathogens showing resistance to our current antifungal products. To bring new antifungals into development, researchers first need to identify new lead molecules. In order to achieve this, they often rely on screening techniques, with phenotypic screening of new compounds being the most preferred. In this presentation, learning’s from several years of research and surveys of the antifungal literature will be shared: unwanted compounds not only adversely affect enzyme assays (figure 1) but also phenotypic screens and hits, as a consequence needs to be selected very carefully. In addition, we would like to share examples of what we believe are good hits for antifungal research but that we were not able to pursue further due to resource limitations. We hope that this will encourage scientists to take some of them forward and help to tackle the global challenge of antifungal research.
Biography

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7